The U.S. Food and Drug Administration (FDA) recently released its Plant and Animal Biotechnology Innovation Action Plan (“Action Plan”). The Action Plan provides an overview of the key priorities FDA expects to pursue through 2020 to support innovation in plant and animal biotechnology. As highlighted in FDA Commissioner Gottlieb’s statement, the agency is committed to fostering innovative advances in the field while ensuring the safety of plant and animal biotechnology products used by consumers. The Action Plan identifies three concepts as critical to FDA’s success in fulfilling its goal: 1) advancing public health by promoting innovation; 2) strengthening public outreach and communication; and 3) increasing engagement with domestic and international partners.